Logo

We Wonder if Someone Gets a Commission on That

Jul 25, 2008

GlaxoSmithKline must have been feeling generous: the pharma gave $25 million to the Harvard Stem Cell Institute for a five-year partnership "to develop new methods for screening drugs with stem cells," according to this news item from Technology Review. "The time appears ripe for investing, because scientists can now use new reprogramming techniques to develop stem cells from patients with specific diseases."

 

Breaking News
The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.